Major nitpick here. Pharmacies aren't pushing anything. Pharmaceutical companies are pushing these drugs.
Worse yet, independent pharmacies have only been losing money selling GLP-1 agonists. Insurance companies have begun to collude using pricing networks. They claim that the market value that pharmacies get the drugs for is too high, even though they are still patented and brand-name, so the insurance and pharmaceutical companies together are the ones that set the price. Then they refuse to reconcile the cost minus the deductible. Last I knew, it was about -42$ on a month prescription.